Characteristics of circulating KSHV-infected viroblasts during active KSHV+ multicentric Castleman disease.
Martin de Frémont G, Vanjak A, Sbihi Z, Knapp S, Garzaro M, Chbihi M, Fournier B, Poirot J, Dossier A, Silvestrini MA, Villemonteix J, Meignin V, Galicier L, Bertinchamp R, Le Goff J, Salmona M, Flamarion E, Cassius C, Lebbé C, Ronchetti AM, Latour S, Oksenhendler E, Carcelain G, Boutboul D.
Martin de Frémont G, et al. Among authors: flamarion e.
Blood Adv. 2023 May 9;7(9):1682-1691. doi: 10.1182/bloodadvances.2022008456.
Blood Adv. 2023.
PMID: 36508281
Free PMC article.